Tandem Diabetes Care Inc SEC filings TNDM
Tandem Diabetes Care Inc has 1,004 filings in SEC EDGAR's recent list, going back to Dec 16, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | May 28, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2025 | — |
| CORRESP | Letter to the SEC | May 23, 2025 | — |
| UPLOAD | Letter from the SEC | May 13, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 27, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| CT ORDER | Filing | Sep 14, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 6, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2019 | — |
| CT ORDER | Filing | Nov 20, 2018 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2018 | — |
| EFFECT | Filing | May 9, 2018 | — |
| CORRESP | Letter to the SEC | May 8, 2018 | — |
| UPLOAD | Letter from the SEC | May 8, 2018 | — |
| EFFECT | Filing | Feb 8, 2018 | — |
| CORRESP | Letter to the SEC | Feb 8, 2018 | — |
| CORRESP | Letter to the SEC | Feb 8, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2018 | — |
| EFFECT | Filing | Dec 22, 2017 | — |
| CORRESP | Letter to the SEC | Dec 20, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2017 | — |
| CT ORDER | Filing | Nov 27, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | May 19, 2017 | — |
| EFFECT | Filing | Mar 22, 2017 | — |
| CORRESP | Letter to the SEC | Mar 21, 2017 | — |
| CORRESP | Letter to the SEC | Mar 21, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2017 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TNDM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438133
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.